Lista de obras -

18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.

artículo científico publicado en 2016

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

artículo científico publicado en 2005

Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.

artículo científico publicado en 2013

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

artículo científico publicado en 2016

Allergy and the bone: unexpected relationships.

artículo científico publicado en 2011

Appropriate use of anabolic treatment for severe osteoporosis

artículo científico publicado en 2010

Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin

scientific article published on 10 December 2011

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros

artículo científico

Bisphosphonates vs infliximab in ankylosing spondylitis treatment.

artículo científico publicado en 2013

Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis.

artículo científico publicado en 2016

Bone involvement and osteoporosis in mastocytosis.

artículo científico

Bone turnover markers in patients with osteogenesis imperfecta

artículo científico publicado en 2004

CD14++ CD16- monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation.

artículo científico publicado en 2016

Capacitively coupled electric field for pain relief in patients with vertebral fractures and chronic pain

artículo científico publicado en 2009

Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.

artículo científico publicado en 2012

Clinical development of neridronate: potential for new applications

artículo científico publicado en 2013

Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.

artículo científico publicado en 2016

DXA bone mineral density in males: retrospective study in real life

artículo científico publicado en 2014

Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011.

artículo científico

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

artículo científico publicado en 2009

Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.

artículo científico publicado en 2015

Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective.

artículo científico publicado en 2008

Drug-induced morphea: report of a case induced by balicatib and review of the literature

artículo científico publicado en 2008

Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

artículo científico publicado en 2009

Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis.

artículo científico publicado en 2016

Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial

artículo científico publicado en 2014

Epidemiology of primary hyperparathyroidism in Europe

artículo científico publicado en 2002

Erratum to: 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.

artículo científico publicado en 2016

Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review

artículo científico publicado en 2011

Focal bone involvement in inflammatory arthritis: the role of IL17.

artículo científico

Glucocorticoid receptors and bone

artículo científico publicado en 2010

High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register

artículo científico publicado en 2013

Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.

artículo científico publicado en 2015

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women

artículo científico publicado en 2010

Injectable bisphosphonates in the treatment of postmenopausal osteoporosis

artículo científico publicado en 2003

Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women

scientific article published on 21 October 2009

Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid.

artículo científico publicado en 2009

Intravenous Neridronate in Children With Osteogenesis Imperfecta: A Randomized Controlled Study

artículo científico publicado en 2004

Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta

artículo científico publicado en 2005

Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.

artículo científico

Long-Term Effects of Neridronate and its Discontinuation in Patients with Primary Hyperparathyroidism

scientific article published on 13 May 2011

Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.

artículo científico publicado en 2007

Medication use before and after hip fracture: a population-based cohort and case-control study

artículo científico publicado en 2014

Neridronic acid for the treatment of bone metabolic diseases.

artículo científico publicado en 2009

Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.

artículo científico publicado en 2009

Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication

artículo científico publicado en 2012

Osteoporosis Treatment: When to Discontinue and When to Re-start

artículo científico publicado en 2013

Osteoporosis treatment: why ibandronic acid?

artículo científico

Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women

artículo científico publicado en 2012

Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.

artículo científico publicado en 2014

Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis.

artículo científico publicado en 2016

Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease.

artículo científico publicado en 2015

Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study

artículo científico publicado en 2015

Prevalence and incidence of rheumatoid arthritis in Italy.

artículo científico publicado en 2014

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture

artículo científico publicado en 2013

Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.

artículo científico publicado en 2015

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).

artículo científico publicado en 2011

Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis

artículo científico

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

artículo científico publicado en 2012

Relationship between leptin levels and bone mineral density in the elderly.

artículo científico publicado en 2003

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

artículo científico publicado en 2014

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2013

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

artículo científico publicado en 2014

Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis

artículo científico publicado en 2016

Safety issues and adverse reactions with osteoporosis management

artículo científico

Sclerostin and DKK1 in Primary Hyperparathyroidism

scientific article published on 22 February 2013

Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis

artículo científico publicado en 2014

Strong relationship between vitamin D status and bone mineral density in anorexia nervosa

artículo científico publicado en 2015

Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I

scientific article published on 02 August 2013

The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study.

artículo científico

The initiative on hip fractures of the Veneto Region

artículo científico publicado en 2012

The role of interleukin-17A in psoriatic disease

artículo científico

The use of bisphosphonates in women: when to use and when to stop.

artículo científico

The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta.

artículo científico publicado en 2003

Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides

artículo científico publicado en 2014

Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study.

artículo científico publicado en 2012

Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials

artículo científico publicado en 2002

Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability

artículo científico publicado en 2010

When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

artículo científico publicado en 2013

Lista de obras de

18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

Acute phase response after zoledronic acid is associated with long-term effects on white blood cells.

Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients

Allergy and the bone: unexpected relationships.

Appropriate use of anabolic treatment for severe osteoporosis

Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin

Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros

Bisphosphonates vs infliximab in ankylosing spondylitis treatment.

Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis.

Bone involvement and osteoporosis in mastocytosis.

Bone turnover markers in patients with osteogenesis imperfecta

CD14++ CD16- monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation.

Capacitively coupled electric field for pain relief in patients with vertebral fractures and chronic pain

Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration.

Clinical development of neridronate: potential for new applications

Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.

DXA bone mineral density in males: retrospective study in real life

Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011.

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis.

Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective.

Drug-induced morphea: report of a case induced by balicatib and review of the literature

Effect of Once-Yearly Zoledronic Acid Five Milligrams on Fracture Risk and Change in Femoral Neck Bone Mineral Density

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis.

Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial

Epidemiology of primary hyperparathyroidism in Europe

Erratum to: 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.

Evidence of sustained vertebral and nonvertebral antifracture efficacy with ibandronate therapy: a systematic review

Focal bone involvement in inflammatory arthritis: the role of IL17.

Glucocorticoid receptors and bone

High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register

Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis.

Impact of prevalent fractures on quality of life: baseline results from the global longitudinal study of osteoporosis in women

Injectable bisphosphonates in the treatment of postmenopausal osteoporosis

Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women

Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid.

Intravenous Neridronate in Children With Osteogenesis Imperfecta: A Randomized Controlled Study

Intravenous bisphosphonate therapy increases radial width in adults with osteogenesis imperfecta

Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.

Long-Term Effects of Neridronate and its Discontinuation in Patients with Primary Hyperparathyroidism

Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight.

Medication use before and after hip fracture: a population-based cohort and case-control study

Neridronic acid for the treatment of bone metabolic diseases.

Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.

Osteonecrosis in systemic lupus erythematosus: an early, frequent, and not always symptomatic complication

Osteoporosis Treatment: When to Discontinue and When to Re-start

Osteoporosis treatment: why ibandronic acid?

Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women

Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.

Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis.

Prevalence and factors related to inappropriately high left ventricular mass in patients with rheumatoid arthritis without overt cardiac disease.

Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study

Prevalence and incidence of rheumatoid arthritis in Italy.

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture

Rationale and design of MUSIC OS-EU: an international observational study of the treatment of postmenopausal women for osteoporosis in Europe and Canada.

Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).

Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures.

Relationship between leptin levels and bone mineral density in the elderly.

Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis

Safety issues and adverse reactions with osteoporosis management

Sclerostin and DKK1 in Primary Hyperparathyroidism

Serum levels of bone cytokines in indolent systemic mastocytosis associated with osteopenia or osteoporosis

Strong relationship between vitamin D status and bone mineral density in anorexia nervosa

Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I

The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study.

The initiative on hip fractures of the Veneto Region

The role of interleukin-17A in psoriatic disease

The use of bisphosphonates in women: when to use and when to stop.

The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta.

Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides

Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study.

Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials

Vitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disability